TipRanksStock Market NewsSLP NewsOppenheimer Remains a Buy on Simulations Plus (SLP)

Oppenheimer Remains a Buy on Simulations Plus (SLP)

In a report released today, Francois Brisebois from Oppenheimer reiterated a Buy rating on Simulations Plus (SLPResearch Report), with a price target of $75.00. The company’s shares closed last Wednesday at $51.28.

According to TipRanks.com, Brisebois is ranked 0 out of 5 stars with an average return of -18.8% and a 25.0% success rate. Brisebois covers the Healthcare sector, focusing on stocks such as Harmony Biosciences Holdings, Tarsus Pharmaceuticals, and Avadel Pharmaceuticals.

Currently, the analyst consensus on Simulations Plus is a Moderate Buy with an average price target of $75.00.

See today’s best-performing stocks on TipRanks >>

Based on Simulations Plus’ latest earnings release for the quarter ending February 28, the company reported a quarterly revenue of $14.8 million and net profit of $4.41 million. In comparison, last year the company earned revenue of $13.15 million and had a net profit of $3.21 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Simulations Plus, Inc. engages in licensing and conducting drug research by pharmaceutical and biotechnology companies. It offers pharmaceutical, and chemical, cosmetics and food industries. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered Lancaster, CA.

Read More on SLP:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More